Atea Pharmaceuticals, Inc.: insider trading
97 trades by 16 directors, officers and 10% owners since 2020, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$168 K
3 sales by 1 insider
Bought, 3 months
$0
0 purchases
Sold, 3 months
$168 K
3 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (16)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Bruce PolskyDirector | 158,580 | — | $168 K | |
| Barbara Gayle DuncanDirector | 92,350 | — | — | |
| Bruno LucidiDirector | 142,350 | — | — | |
| Franklin M. BergerDirector | 536,097 | — | — | |
| Jerome M. AdamsDirector | 92,350 | — | — | |
| Polly A. MurphyDirector | 121,745 | — | — | |
| Andrea CorcoranSee Remarks | 823,576 | — | — | |
| Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | 767,830 | — | — | |
| Janet Mj HammondChief Development Officer | 127,665 | — | — | |
| John VavrickaChief Commercial Officer | 82,594 | — | — | |
| Maria Arantxa HorgaChief Medical Officer | 96,086 | — | — | |
| Wayne FosterEVP, Chief Accounting Officer | 79,329 | — | — | |
| Andrew A. F. HackDirector | — | — | — | |
| Chung K. Chu10% owner | 1.18 M | — | — | |
| Cormorant Asset Management, LPFormer 10% Owner | — | — | — | |
| Rock Springs Capital Master Fund LP10% owner | — | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Bruce PolskyDirector | Option exercise | +18,252 | $1.240 | $23 K | 176,832 | Form 4 |
| filed | Bruce PolskyDirector | Sell | -18,252 | $3.950 | $72 K | 158,580 | Form 4 |
| filed | Bruce PolskyDirector | Option exercise | +8,720 | $1.240 | $11 K | 167,300 | Form 4 |
| filed | Bruce PolskyDirector | Sell | -8,720 | $4.032 | $35 K | 158,580 | Form 4 |
| filed | Bruce PolskyDirector | Option exercise | +48,028 | $1.240 | $60 K | 172,834 | Form 4 |
| filed | Bruce PolskyDirector | Sell | -14,254 | $4.268 | $61 K | 158,580 | Form 4 |
| filed | Franklin M. BergerDirector | Option exercise | +29,600 | — | — | 536,097 | Form 4 |
| filed | Bruce PolskyDirector | Option exercise | +29,600 | — | — | 124,806 | Form 4 |
| filed | Polly A. MurphyDirector | Option exercise | +29,600 | — | — | 121,745 | Form 4 |
| filed | Bruno LucidiDirector | Option exercise | +29,600 | — | — | 142,350 | Form 4 |
| filed | Jerome M. AdamsDirector | Option exercise | +29,600 | — | — | 92,350 | Form 4 |
| filed | Barbara Gayle DuncanDirector | Option exercise | +29,600 | — | — | 92,350 | Form 4 |
| filed | Polly A. MurphyDirector | Buyamended | +6,100 | $4.170 | $25 K | 92,145 | Form 4/A |
| filed | Andrea CorcoranSee Remarks | Option exercise | +60,000 | $1.240 | $74 K | 823,576 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Option exercise | +300,000 | $1.240 | $372 K | 767,830 | Form 4 |
| filed | Janet Mj HammondChief Development Officer | Option exercise | +58,050 | — | — | 141,801 | Form 4 |
| filed | Wayne FosterEVP, Chief Accounting Officer | Option exercise | +41,333 | — | — | 91,461 | Form 4 |
| filed | Andrea CorcoranSee Remarks | Option exercise | +54,866 | — | — | 779,680 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Option exercise | +272,983 | — | — | 573,923 | Form 4 |
| filed | John VavrickaChief Commercial Officer | Option exercise | +42,083 | — | — | 94,164 | Form 4 |
| filed | Maria Arantxa HorgaChief Medical Officer | Option exercise | +51,283 | — | — | 112,159 | Form 4 |
| filed | Janet Mj HammondChief Development Officer | Shares withheld for tax | -14,136 | $4.240 | $60 K | 127,665 | Form 4 |
| filed | Andrea CorcoranSee Remarks | Shares withheld for tax | -16,104 | $4.240 | $68 K | 763,576 | Form 4 |
| filed | John VavrickaChief Commercial Officer | Shares withheld for tax | -11,570 | $4.240 | $49 K | 82,594 | Form 4 |
| filed | Wayne FosterEVP, Chief Accounting Officer | Shares withheld for tax | -12,132 | $4.240 | $51 K | 79,329 | Form 4 |
| filed | Maria Arantxa HorgaChief Medical Officer | Shares withheld for tax | -16,073 | $4.240 | $68 K | 96,086 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Shares withheld for tax | -106,093 | $4.240 | $450 K | 467,830 | Form 4 |
| filed | Bruno LucidiDirector | Option exercise | +29,600 | — | — | 112,750 | Form 4 |
| filed | Polly A. MurphyDirector | Option exercise | +29,600 | — | — | 86,045 | Form 4 |
| filed | Franklin M. BergerDirector | Option exercise | +29,600 | — | — | 506,497 | Form 4 |
| filed | Barbara Gayle DuncanDirector | Option exercise | +29,600 | — | — | 62,750 | Form 4 |
| filed | Bruce PolskyDirector | Option exercise | +29,600 | — | — | 95,206 | Form 4 |
| filed | Jerome M. AdamsDirector | Option exercise | +29,600 | — | — | 62,750 | Form 4 |
| filed | Polly A. MurphyDirector | Buy | +6,100 | $4.170 | $25 K | 92,145 | Form 4 |
| filed | John VavrickaChief Commercial Officer | Option exercise | +33,333 | — | — | 54,848 | Form 4 |
| filed | Wayne FosterEVP, Chief Accounting Officer | Option exercise | +33,333 | — | — | 54,190 | Form 4 |
| filed | Andrea CorcoranSee Remarks | Option exercise | +44,367 | — | — | 722,909 | Form 4 |
| filed | Maria Arantxa HorgaChief Medical Officer | Option exercise | +41,533 | — | — | 67,197 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Option exercise | +173,467 | — | — | 290,024 | Form 4 |
| filed | Janet Mj HammondChief Development Officer | Option exercise | +46,800 | — | — | 84,272 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Grant or award | +99,517 | — | — | 389,541 | Form 4 |
| filed | Maria Arantxa HorgaChief Medical Officer | Grant or award | +9,750 | — | — | 76,947 | Form 4 |
| filed | Andrea CorcoranSee Remarks | Grant or award | +10,500 | — | — | 733,409 | Form 4 |
| filed | Wayne FosterEVP, Chief Accounting Officer | Grant or award | +8,000 | — | — | 62,190 | Form 4 |
| filed | Janet Mj HammondChief Development Officer | Grant or award | +11,250 | — | — | 95,522 | Form 4 |
| filed | John VavrickaChief Commercial Officer | Grant or award | +8,750 | — | — | 63,598 | Form 4 |
| filed | Wayne FosterEVP, Chief Accounting Officer | Shares withheld for tax | -12,062 | $3.060 | $37 K | 50,128 | Form 4 |
| filed | John VavrickaChief Commercial Officer | Shares withheld for tax | -11,517 | $3.060 | $35 K | 52,081 | Form 4 |
| filed | Andrea CorcoranSee Remarks | Shares withheld for tax | -16,102 | $3.060 | $49 K | 717,307 | Form 4 |
| filed | Maria Arantxa HorgaChief Medical Officer | Shares withheld for tax | -16,071 | $3.060 | $49 K | 60,876 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Shares withheld for tax | -88,601 | $3.060 | $271 K | 300,940 | Form 4 |
| filed | Janet Mj HammondChief Development Officer | Shares withheld for tax | -14,134 | $3.060 | $43 K | 81,388 | Form 4 |
| filed | Franklin M. BergerDirector | Buyamended | +10,000 | $3.360 | $34 K | 476,897 | Form 4/A |
| filed | Franklin M. BergerDirector | Buy | -10,000 | $3.360 | $34 K | 476,897 | Form 4 |
| filed | Franklin M. BergerDirector | Buyamended | +15,000 | $3.190 | $48 K | 466,897 | Form 4/A |
| filed | Franklin M. BergerDirector | Buy | -15,000 | $3.190 | $48 K | 466,897 | Form 4 |
| filed | Franklin M. BergerDirector | Sell | -359,606 | $2.850 | $1.0 M | 451,897 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Sell10b5-1 plan · indirect | -1,841 | $4.000 | $7 K | 5.87 M | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Sell10b5-1 plan · indirect | -22,187 | $4.030 | $89 K | 5.87 M | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Sell10b5-1 plan · indirect | -33,941 | $4.050 | $137 K | 5.89 M | Form 4 |
| filed | Bruce PolskyDirector | Sell | -17,544 | $3.490 | $61 K | 65,606 | Form 4 |
| filed | Jerome M. AdamsDirector | Option exercise | +33,150 | — | — | 33,150 | Form 4 |
| filed | Polly A. MurphyDirector | Option exercise | +33,150 | — | — | 56,445 | Form 4 |
| filed | Barbara Gayle DuncanDirector | Option exercise | +33,150 | — | — | 33,150 | Form 4 |
| filed | Franklin M. BergerDirector | Option exercise | +33,150 | — | — | 811,503 | Form 4 |
| filed | Bruce PolskyDirector | Option exercise | +33,150 | — | — | 83,150 | Form 4 |
| filed | Bruno LucidiDirector | Option exercise | +33,150 | — | — | 83,150 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Sell10b5-1 plan · indirect | -1,006 | $4.000 | $4 K | 5.92 M | Form 4 |
| filed | John VavrickaChief Commercial Officer | Sell10b5-1 plan | -11,819 | $3.840 | $45 K | 21,515 | Form 4 |
| filed | Andrea CorcoranSee Remarks | Sell10b5-1 plan | -15,843 | $3.840 | $61 K | 670,208 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Sell10b5-1 plan | -56,910 | $3.850 | $219 K | 116,557 | Form 4 |
| filed | Janet Mj HammondChief Development Officer | Sell10b5-1 plan | -14,029 | $3.840 | $54 K | 35,362 | Form 4 |
| filed | Maria Arantxa HorgaChief Medical Officer | Sell10b5-1 plan | -15,870 | $3.840 | $61 K | 25,664 | Form 4 |
| filed | Wayne FosterEVP, Chief Accounting Officer | Sell10b5-1 plan | -12,477 | $3.840 | $48 K | 20,857 | Form 4 |
| filed | John VavrickaChief Commercial Officer | Option exercise | +33,334 | — | — | 33,334 | Form 4 |
| filed | Andrea CorcoranSee Remarks | Option exercise | +44,367 | — | — | 686,051 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Option exercise10b5-1 plan | +173,467 | — | — | 173,467 | Form 4 |
| filed | Janet Mj HammondChief Development Officer | Option exercise | +46,800 | — | — | 49,391 | Form 4 |
| filed | Maria Arantxa HorgaChief Medical Officer | Option exercise | +41,534 | — | — | 41,534 | Form 4 |
| filed | Wayne FosterEVP, Chief Accounting Officer | Option exercise | +33,334 | — | — | 33,334 | Form 4 |
| filed | Franklin M. BergerDirector | Sell | -16,166 | $5.160 | $83 K | 778,353 | Form 4 |
| filed | Franklin M. BergerDirector | Sell | -25,500 | $5.150 | $131 K | 794,519 | Form 4 |
| filed | Polly A. MurphyDirector | Buy | +12,000 | $8.570 | $103 K | 23,295 | Form 4 |
| filed | Cormorant Asset Management, LPFormer 10% Owner | Conversionindirect | +6.41 M | — | — | 6.41 M | Form 4 |
| filed | Rock Springs Capital Master Fund LP10% owner | Conversionindirect | +1.41 M | — | — | 1.41 M | Form 4 |
| filed | Rock Springs Capital Master Fund LP10% owner | Conversionindirect | +282,403 | — | — | 282,403 | Form 4 |
| filed | Rock Springs Capital Master Fund LP10% owner | Buyindirect | +242,708 | $24.00 | $5.8 M | 1.65 M | Form 4 |
| filed | Rock Springs Capital Master Fund LP10% owner | Buyindirect | +7,292 | $24.00 | $175 K | 289,695 | Form 4 |
| filed | Andrew A. F. HackDirector | Conversionindirect | +5.37 M | — | — | 5.37 M | Form 4 |
| filed | John VavrickaChief Commercial Officer | Conversionindirect | +82,508 | — | — | 82,508 | Form 4 |
| filed | Franklin M. BergerDirector | Conversion | +759,606 | — | — | 778,353 | Form 4 |
| filed | Chung K. Chu10% owner | Conversion | +176,862 | — | — | 1.18 M | Form 4 |
| filed | Andrea CorcoranSee Remarks | Conversion | +133,004 | — | — | 633,004 | Form 4 |
| filed | Jean-Pierre SommadossiPresident, CEO, and Chairman, Director | Conversionindirect | +750,000 | — | — | 5.92 M | Form 4 |
| filed | Polly A. MurphyDirector | Conversionindirect | +11,295 | — | — | 11,295 | Form 4 |
| filed | Franklin M. BergerDirector | Buy | +41,666 | $24.00 | $1000 K | 820,019 | Form 4 |
| filed | Andrew A. F. HackDirector | Buyindirect | +250,000 | $24.00 | $6.0 M | 5.62 M | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice